Litcius/Paper detail

Hairy-Cell Leukemia

Brunangelo Falini, Enrico Tiacci

2024New England Journal of Medicine34 citationsDOI

Abstract

Hairy-cell leukemia, a rare B-cell cancer driven by a BRAF mutation and manifesting with cytopenias and splenomegaly, is responsive to purine analogue chemotherapy and to BRAF inhibitors combined with anti-CD20 antibodies.

Topics & Concepts

LeukemiaHairy cell leukemiaCancer researchComputational biologyMedicineBiologyImmunologyChronic Lymphocytic Leukemia ResearchImmunodeficiency and Autoimmune DisordersImmune Cell Function and Interaction
Hairy-Cell Leukemia | Litcius